Insider selling
Traded Jun 12, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
A Pulmonx director sold $25K of Pulmonx shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 2, 2025 · Filed Jun 4, 2025
The CFO of Pulmonx sold $12K of Pulmonx shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$11,647
Shares × reported transaction price
33 days after results of Apr 30, 2025, 58 days before results of Jul 30, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Insider selling
Traded Jun 12, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
A Pulmonx director sold $25K of Pulmonx shares. The filing does not indicate a pre-arranged trading plan.
Insider buying
Traded Jun 5, 2025 · filed 1 day later
A Pulmonx director paid $71K out of pocket for Pulmonx shares. Shares held went up 25% with this purchase.
David Aaron Lehman (GENERAL COUNSEL) sold ~$1.7K of Pulmonx
Automatic saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.